RESUMO
Parvovirus B19 (B19V) has been associated with a wide spectrum of clinico‑pathological disorders in human beings depending upon the host immunity. The present report describes a child with chronic myeloid leukemia (CML) on hydroxyurea in haematological remission, who developed profound erythroid suppression following B19V infection requiring multiple transfusions and withdrawal of hydroxyurea. Despite being off-therapy the child remained in complete clinical and haematological remission till anti B19V antibodies appeared. This case illustrates the ability of B19V infection in suppressing neoplastic myeloid clone, a phenomenon not described earlier.
RESUMO
Hidrops fetal no inmunológico diagnosticado a las 22 semanas de gestación, secundario a infección por Parvovirus B19, tratado exitosamente con cinco transfusiones intrauterinas. Parto vaginal con recién nacido de término sin estigmas de enfermedad. Enfatizamos la importancia de sospechar el diagnóstico, el manejo basado en Vmax de ACM y la capacidad actual de tratamiento exitoso a través de transfusiones intrauterinas.
Non immunologic hydrops fetalis diagnosed at 22 weeks of gestation, secondary to infection by Parvovirus B19, successfully treated with five intrauterine transfusions. Vaginal delivery at 37 weeks without stigmata of disease. We emphasize the importance of suspecting the diagnosis, management based on Vmax of ACM and the current capacity of successful treatment by intrauterine transfusion.